Transcend Medical Garners $22,000,000 Series C Financing

  • Feed Type
  • Date
    4/2/2014
  • Company Name
    Transcend Medical
  • Mailing Address
    127 Independence Drive Menlo Park, CA 94025 USA
  • Company Description
    Transcend Medical, Inc. is focused on the research and development of novel devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. Over two million people in the U.S. alone are afflicted with the disease today and the numbers are expected to grow to three million by the year 2020.
  • Website
    http://www.transcendmedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The funds will support completion of the US-based, randomized, controlled COMPASS pivotal trial evaluating the CyPass® Micro-Stent, a next-generation, micro-invasive glaucoma implant, in the largest enrolled glaucoma surgery study to date.
  • M&A Terms
  • Venture Investor